Zhejiang Cheng Yi Pharmaceutical Co.,Ltd.’s Net Profit Dropped 13.5% in First Three Quarters of 2022

Zhejiang Cheng Yi Pharmaceutical Co.,Ltd. (浙江诚意药业股份有限公司) (603811.SH) reported a net profit of 102.5 million yuan in the first three quarters of 2022, down 13.5% year-on-year.

Meanwhile, the company posted 476.2 million yuan in revenue, down 9.1% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 564.4 million yuan in total liabilities, with a liability-to-asset ratio of 35.4%.